openPR Logo
Press release

Urinalysis Market to Reach USD 9.02 Billion by 2032, Growing at a 9.1% CAGR, Says DelveInsight

12-18-2025 03:52 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Urinalysis Market

Urinalysis Market

According to DelveInsight's assessment, the rising prevalence of urinary disorders such as urinary tract infections (UTIs), chronic kidney disease, and hospital-acquired infections is driving strong demand for urinalysis testing, as early diagnosis is essential for timely and effective treatment.

Growing public awareness of health and wellness, along with government-led and private healthcare initiatives, is encouraging individuals to opt for routine diagnostic screenings. In parallel, educational efforts by healthcare providers continue to emphasize the role of urinalysis in preventive care. Moreover, continuous innovation by leading manufacturers is resulting in the launch of advanced, user-friendly urinalysis solutions that enhance diagnostic accuracy while streamlining laboratory workflows.

DelveInsight's report titled "Urinalysis Market Insights, Competitive Landscape and Market Forecast-2032" delivers an in-depth evaluation of the current and future market outlook. It highlights upcoming technological advancements, key growth drivers, challenges, and market barriers, while also profiling prominent emerging products and leading companies shaping the global urinalysis landscape.

To understand why North America continues to dominate the urinalysis market, explore the report snapshot on Urinalysis Market Trends: https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Urinalysis Overview
Urinalysis is a commonly performed diagnostic procedure that analyzes a urine sample to evaluate overall health and identify a range of medical conditions. The test assesses physical characteristics, chemical components, and microscopic contents such as cells, crystals, and microorganisms. It is widely used for detecting UTIs, kidney disorders, metabolic abnormalities, and diseases such as diabetes. Due to its non-invasive nature, simplicity, and speed, urinalysis is frequently included in routine health examinations and pre-operative assessments.

DelveInsight Analysis
The global urinalysis market was valued at USD 4,510.55 million in 2024 and is expected to expand at a CAGR of 9.10% between 2025 and 2032, reaching approximately USD 9,021.90 million by 2032.

Urinalysis Market Insights
From a regional perspective, North America is anticipated to command the largest share of the urinalysis market in 2024. This leadership is attributed to the growing incidence of UTIs, kidney diseases, and diabetes, all of which necessitate frequent diagnostic testing. The region benefits from a well-established healthcare system and widespread adoption of advanced diagnostic technologies, including automated urine analyzers and point-of-care testing solutions. Increased emphasis on preventive healthcare, along with favorable government policies and regulatory approvals for innovative products, is further accelerating market growth across North America.

To explore the latest developments and insights in greater detail, access the Urinalysis Market Key Highlights: https://www.delveinsight.com/report-store/urinalysis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Recent Developments in the Urinalysis Market
• In August 2024, Carolina Liquid Chemistries entered a partnership with Medline to distribute fentanyl screening tests for urinalysis applications.
• In July 2024, Mexple introduced UroMen and UroWomen urine collection kits.
• These strategic developments are expected to support accelerated growth of the urinalysis market throughout the forecast period.

Key Players in the Urinalysis Market
Major companies operating in the global urinalysis market include F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Siemens Healthcare Private Limited, Sysmex Europe SE, Abbott, Carolina Liquid Chemistries, Medline Industries, LP, Mexple, Olive Diagnostics, ACON Laboratories, Thermo Fisher Scientific, Arkray, Inc., DIRUI Industrial Co., Ltd., Mindray Medical International, Eiken Chemical Co., Ltd., Greiner Bio-One, LabCorp, Sekisui Diagnostics, Teco Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., among others.

To discover which MedTech companies are poised to emerge as key trendsetters in the urinalysis space, explore Key Urinalysis Companies: https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Analysis of the Urinalysis Market Landscape
Automated urine analyzers are playing a pivotal role in expanding access to high-quality urinalysis services, particularly in smaller clinics and diagnostic laboratories. These systems enhance efficiency and consistency while reducing manual errors. Ongoing technological advancements and sustained product innovation continue to reinforce market momentum. For example, in September 2022, Sysmex Corporation launched the UF-1500, a fully automated urine particle analyzer designed for sediment analysis. The system retains the performance strengths of the UF-5000 while incorporating user-driven enhancements for improved usability.

Collectively, these advancements are expected to drive strong growth in the automated urine analyzers segment, supporting the overall expansion of the global urinalysis market.

Scope of the Urinalysis Market Report
• Coverage: Global
• Study Period: 2022-2032
• Market Segmentation by Product:
Instruments (Automated Urine Analyzers, Semi-automated Urine Analyzers, Point-of-Care Testing Urinalysis) and Consumables (Reagents, Kits, and Others)
• Market Segmentation by Test Type:
Biochemical Urinalysis, Microscopic Urinalysis, and Others
• Market Segmentation by End User:
Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others
• Market Segmentation by Geography:
North America, Europe, Asia-Pacific, and Rest of the World
• Key Companies Covered:
F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Siemens Healthcare Private Limited, Sysmex Europe SE, Abbott, Carolina Liquid Chemistries, Medline Industries, LP, Mexple, Olive Diagnostics, ACON Laboratories, Thermo Fisher Scientific, Arkray, Inc., DIRUI Industrial Co., Ltd., Mindray Medical International, Eiken Chemical Co., Ltd., Greiner Bio-One, LabCorp, Sekisui Diagnostics, Teco Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and others
• Additional Analysis:
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL Insights, and Analyst Perspectives

Interested in understanding how the urinalysis market will evolve through 2032? Click here to access the Urinalysis Market Analysis Snapshot: https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urinalysis Market to Reach USD 9.02 Billion by 2032, Growing at a 9.1% CAGR, Says DelveInsight here

News-ID: 4319883 • Views:

More Releases from DelveInsight Business Research

Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by 240,000+ Diagnosed Cases Across 7MM, estimates DelveInsight
Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by …
In 2023, the Limbal Stem Cell Deficiency (LSCD) market was dominated by the United States, generating nearly USD 1.5 billion in revenue, while Spain represented the smallest market with approximately USD 127 million. This regional distribution is expected to remain consistent throughout the forecast timeline. The US accounted for nearly 103,000 diagnosed LSCD cases, whereas Japan recorded around 37,000 cases, with both countries projected to witness notable growth in patient
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Therapies, estimates DelveInsight
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Ther …
The major players operating in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market include Roche, Prometheus Biosciences, Inc., Merck, GlaxoSmithKline, Genentech, Inc., Acceleron, Boehringer Ingelheim, Actelion, Hôpital Claude-Huriez, Changchun GeneScience Pharmaceutical, among others. DelveInsight's report titled "Systemic Sclerosis-associated Interstitial Lung Disease Market Insights, Epidemiology, and Forecast-2034" delivers a comprehensive analysis of SSc-ILD, covering historical data, projected epidemiology, and evolving market trends across the United States, EU4 (Germany, Spain, Italy, and France),
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerated Expansion, Fueled by Targeted Therapies and a Growing Innovation Pipeline, Says DelveInsight
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerat …
The Developmental and Epileptic Encephalopathy (DEE) treatment market across the seven major markets (7MM) was valued at nearly USD 2.1 billion in 2023 and is expected to register a healthy compound annual growth rate over the forecast period. The United States emerged as the largest contributor, capturing close to 80% of the overall market revenue. The DEE treatment landscape is undergoing a significant transformation as the limitations of traditional antiepileptic drugs
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Companies Reshaping the Treatment Landscape, estimates DelveInsight
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Co …
DelveInsight's "Polycythemia Vera Pipeline Insight 2025" report delivers an in-depth overview of the Polycythemia Vera pipeline landscape, covering more than 8 companies and 10+ pipeline candidates. The report analyzes both clinical-stage and preclinical assets, offering detailed drug profiles across various stages of development. It also evaluates Polycythemia Vera therapies based on product classification, development stage, route of administration, and molecular category, while additionally spotlighting inactive or discontinued pipeline assets. Explore the

All 5 Releases


More Releases for Urinalysis

Geriatric Population Surge Fuels Growth In The Urinalysis Market: An Emerging Dr …
The Urinalysis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Urinalysis Market? The size of the urinalysis market has witnessed significant growth over the last few years. It is projected to rise from a valuation of $3.57 billion in
Global Urinalysis Strips Market Size by Application, Type, and Geography: Foreca …
USA, New Jersey- According to Market Research Intellect, the global Urinalysis Strips market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The market for urinalysis strips is steadily growing due to the rising incidence of renal disorders, diabetes, and urinary tract infections (UTIs). The ease of
Urinalysis Test Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Urinalysis Test Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. Urinalysis Test Market Definition, With Current Market Values The urinalysis test market encompasses the development, production, and distribution of diagnostic products and services used to analyze
Urinalysis Market Demand for Urinalysis Is Expected To Provide Opportunities for …
Urinalysis Market Outlook 2022-2029 The Urinalysis Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The global urinalysis market is expected to grow at more than 7.2% CAGR from 2022 to 2029. It is expected to reach above USD 6.1 billion by 2029
Urinalysis Market
A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems.  A urine test includes three parts namely, visual exam, microscopic exam, and dipstick
Urinalysis Market
A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems.  A urine test includes three parts namely, visual exam, microscopic exam, and dipstick